Microbiologic efficacy of moxifloxacin for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae

This publication has 13 references indexed in Scilit:

• Sparfloxacin vs Ofloxacin in the Treatment of Acute Bacterial Exacerbations of Chronic Bronchitis
  Chest, 1998
• Trovafloxacin versus amoxicillin/clavulanic acid in the treatment of acute exacerbations of chronic obstructive bronchitis
  European Journal of Clinical Microbiology & Infectious Diseases, 1998
• In Vitro Activity of a New 8-Methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae
  Antimicrobial Agents and Chemotherapy, 1998
• Community‐Acquired Pneumonia in Adults: Guidelines for Management
  Clinical Infectious Diseases, 1998
• Microbiologic Efficacy of Azithromycin and Susceptibilities to Azithromycin of Isolates of Chlamydia pneumoniae from Adults and Children with Community-Acquired Pneumonia
  Antimicrobial Agents and Chemotherapy, 1998
• A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia
  Antimicrobial Agents and Chemotherapy, 1997
• Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric community-acquired pneumonia
  The Pediatric Infectious Disease Journal, 1995
• In vitro activities of azithromycin, clarithromycin, L-ofloxacin, and other antibiotics against Chlamydia pneumoniae
  Antimicrobial Agents and Chemotherapy, 1992
• Ofloxacin treatment of Chlamydia pneumoniae (strain TWAR) lower respiratory tract infections
  The American Journal of Medicine, 1990
• A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWAR
  The Journal of Infectious Diseases, 1990